Preference for injectable over oral HIV pre-exposure prophylaxis in public-sector primary-care clinics in Swaziland

AIDS. 2018 Jul 17;32(11):1541-1542. doi: 10.1097/QAD.0000000000001859.

Abstract

: Long-acting injectable (LAI) HIV pre-exposure prophylaxis (PrEP) may mitigate adherence challenges reported by young women in Southern Africa. We assessed preferences for PrEP in public-sector, primary care clinics in Swaziland. Among surveyed respondents, 75% (95% confidence interval = 65-83%) stated preference for LAI over oral PrEP; with no differences by sex, age, or sexual behavior (all P > 0.05). Notably, over 70% (95% confidence interval 58-82%) with current use of oral PrEP also stated preference for LAI PrEP.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anti-HIV Agents / administration & dosage*
  • Delayed-Action Preparations / administration & dosage*
  • Eswatini
  • Female
  • HIV Infections / prevention & control*
  • Humans
  • Injections / statistics & numerical data*
  • Male
  • Middle Aged
  • Pre-Exposure Prophylaxis / methods*
  • Primary Health Care / methods*
  • Public Sector*
  • Young Adult

Substances

  • Anti-HIV Agents
  • Delayed-Action Preparations